21 CFR 211.22(a) citations
FDA investigators cited 21 CFR 211.22(a) 835 times at 746 facilities in the inspection citations FDA publishes, most recently in an inspection that ended Aug 12, 2026. A citation is an observation listed on Form FDA 483 at the end of an inspection; it is not a final agency decision.
Citations by fiscal year
| FDA fiscal year | Citations |
|---|---|
| 2026 | 28 |
| 2025 | 51 |
| 2024 | 51 |
| 2023 | 35 |
| 2022 | 41 |
| 2021 | 17 |
| 2020 | 26 |
| 2019 | 56 |
| 2018 | 61 |
| 2017 | 66 |
Recent citations
The latest inspections that cited this section. Facility names link to each facility's FDA record.
| Inspection ended | Facility | Country | Observation |
|---|---|---|---|
| Aug 12, 2026 | Mountainside Medical Equipment, Inc. | United States | There is no quality control unit. |
| Jul 17, 2026 | I. Shay Cosmetics Inc | United States | The quality control unit lacks the responsibility and authority to approve and reject all components, drug product containers, closures, in process materials, packaging material, labeling and drug products. |
| Jun 12, 2026 | The Flower Remedy LLC | United States | The quality control unit lacks the responsibility and authority to approve and reject all components, drug product containers, closures, in process materials, packaging material, labeling and drug products. |
| Jun 5, 2026 | My CHS Rx, Inc. | United States | There is no quality control unit. |
| Jun 4, 2026 | Nexus Pharmaceuticals, LLC | United States | The quality control unit lacks authority to fully investigate errors that have occurred. |
| May 20, 2026 | Talbot's Pharmaceuticals Family Products, LLC | United States | The quality control unit lacks responsibility for approving or rejecting drug products manufactured, processed and packed under contract by another company. |
| May 1, 2026 | GVS TM, Inc | United States | The quality control unit lacks the responsibility and authority to approve and reject all components, drug product containers, closures, in process materials, packaging material, labeling and drug products. |
| Mar 19, 2026 | PReye LLC | United States | There is no quality control unit. |
| Mar 10, 2026 | Cosmetic Lab, Inc. | United States | The quality control unit lacks the responsibility and authority to approve and reject all components. |
| Mar 5, 2026 | SURETEC INNOVATIONS LLC | United States | There is no quality control unit. |
| Feb 19, 2026 | LICO Industries, LLC | United States | There is no quality control unit. |
| Feb 5, 2026 | Fenwal International, Inc. | United States | The quality control unit lacks authority to fully investigate errors that have occurred. |
| Feb 5, 2026 | NexCell Scientific Inc | United States | There is no quality control unit. |
| Jan 30, 2026 | Safrel Pharmaceuticals LLC | United States | There is no quality control unit. |
| Jan 16, 2026 | Dabur India Limited | India | The quality control unit lacks authority to review production records to assure that no errors have occurred and fully investigate errors that have occurred. |
| Jan 12, 2026 | Skytronics Led, Inc | United States | There is no quality control unit. |
| Dec 19, 2025 | KaryoLogic Inc | United States | There is no quality control unit. |
| Dec 16, 2025 | Bello Bio LLC | United States | There is no quality control unit. |
| Dec 16, 2025 | Regen Suppliers LLC | United States | There is no quality control unit. |
| Dec 4, 2025 | St Mary's Medical Park Pharmacy | United States | There is no quality control unit. |
| Nov 28, 2025 | Analytical Solutions | India | The quality control unit lacks authority to fully investigate errors that have occurred. |
| Nov 21, 2025 | Eagle Analytical Services, Inc. | United States | The quality control unit lacks authority to review production records to assure that no errors have occurred and fully investigate errors that have occurred. |
| Nov 21, 2025 | Sato Pharmaceutical Co., Ltd. | Japan | The quality control unit lacks the responsibility and authority to approve and reject all drug products. |
| Nov 20, 2025 | WES Pharma Inc. | United States | The quality control unit lacks authority to fully investigate errors that have occurred. |
| Nov 18, 2025 | Actavis Laboratories FL, Inc. | United States | The quality control unit lacks authority to review production records to assure that no errors have occurred and fully investigate errors that have occurred. |
Search more
Search every Form 483 citation by company with the FDA 483 search, see all frequently cited CFR sections, or check one supplier with the free FDA compliance check.